Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDUA | P35475 | 1/20 | 0.50 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.48 |
| ▸ | FGF2 | P09038 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | AHCY | P23526 | 1/20 | 0.31 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | GBA1 | P04062 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glucuronate SCHEMBL13324585 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL15596891 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL15177391 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL20094857 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL13376995 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL6404275 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL25253417 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL21792734 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL21312643 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL22749019 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117990732-B | Polysaccharide structure analysis method based on separated segmented homologous polysaccharide groups | 浙江大学 | 2024-06-25 | — | — | CN | disclosed |
| CN-117990732-A | Polysaccharide structure analysis method based on separated segmented homologous polysaccharide groups | 浙江大学 | 2024-05-07 | — | — | CN | disclosed |
| US-20050123533-A1 | Prodrugs activated by targeted catalytic proteins | WELLSTAT BIOCATALYSIS, LLC | 2005-06-09 | — | — | US | disclosed |
| US-6702705-B1 | Prodrugs activated by targeted catalytic proteins | IGEN INTERNATIONAL, INC. | 2004-03-09 | — | — | US | disclosed |
| US-20030096765-A1 | Prodrugs activated by targeted catalytic proteins | IGEN, INC. | 2003-05-22 | — | — | US | disclosed |
| US-6258360-B1 | BENZOATE CONJUGATES; ANTITUMOR AGENTS | IGEN INTERNATIONAL, INC. | 2001-07-10 | — | — | US | disclosed |
| EP-0746336-A1 | PRODRUGS ACTIVATED BY TARGETED CATALYTIC PROTEINS | IGEN, INC. (US) | 1996-12-11 | — | — | EP | disclosed |
| EP-0746336-A4 | PRODRUGS ACTIVATED BY TARGETED CATALYTIC PROTEINS | IGEN INC (US) | 1996-07-26 | — | — | EP | disclosed |
| WO-1993002703-A1 | PRODRUGS ACTIVATED BY TARGETED CATALYTIC PROTEINS | IGEN, INC. (US) | 1993-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050123533-A1 | Prodrugs activated by targeted catalytic proteins | DNPH1, DNPEP, PNP | IDUA 571/4885SUCNR1 4065/4885FGF2 4745/4885 |
| US-20030096765-A1 | Prodrugs activated by targeted catalytic proteins | DNPH1, DNPEP, PNP | IDUA 571/4885SUCNR1 4065/4885FGF2 4745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.